Mansbach Harry H 4
4 · 89bio, Inc. · Filed Feb 4, 2025
Insider Transaction Report
Form 4
89bio, Inc.ETNB
Mansbach Harry H
Chief Medical Officer
Transactions
- Award
Common Stock
2025-02-01+80,000→ 327,039 total - Award
Stock Option (Right to Buy)
2025-02-01+320,000→ 320,000 totalExercise: $9.60Exp: 2035-02-01→ Common Stock (320,000 underlying) - Tax Payment
Common Stock
2025-02-01$9.60/sh−3,338$32,045→ 323,701 total
Footnotes (3)
- [F1]Represents restricted stock units that vest in equal semi-annual installments over three years, subject to the Reporting Person's continued service to the Issuer.
- [F2]These shares were withheld from the vesting of restricted stock units to cover the estimated tax withholding obligation.
- [F3]Represents a right to purchase a total of 320,000 shares of the Issuer's Common Stock, one quarter of which will vest on February 1, 2026, with the remaining three quarters vesting in equal quarterly installments over the following three years, subject to the Reporting Person's continued service to the Issuer.